A bioengineered vinpocetine- and menstrual blood stem cell-loaded neural conduit for treating peripheral nerve injury after bone fractures Authors: Guoshan Li, Yuxin Yan, Yong Hou, Guangsheng Zhao, Xiaodong Wang, Min Cui, Huyu Du Published: 2025 ABSTRACT AbstractBackgroundPeripheral nerve injury (PNI) poses a significant clinical challenge, often resulting in incomplete functional recovery. This study aimed to develop and evaluate a multifunctional neural guidance conduit combining electrospun PCL/collagen scaffolds with a collagen hydrogel incorporating vinpocetine-loaded chitosan nanoparticles (VINCNPs) and menstrual blood-derived stem cells (MenSCs).MethodsElectrospun PCL/collagen scaffolds loaded with bioactive collagen hydrogel containing VINCNPs and MenSCs (HYDVINMEN) were prepared. The scaffold-hydrogel constructs were evaluated for physicochemical, mechanical and biological properties in vitro, including cell viability and hemocompatibility. In vivo recovery of motor and sensory function, preservation of muscle, axonal regeneration, and inflammatory and neurotrophic responses were assessed in a rat sciatic nerve transection model.ResultsNanocarriers achieved a cumulative drug release of 63.37 ± 5.05% at 168 h. Tensile strength analysis showed that PCL/collagen scaffolds had around 3.387 ± 0.434 MPa of ultimate tensile strength. HYDVINMEN group showed better cell viability, swelling and degradation control, and low hemolytic activity. In vivo study of this group showed better sciatic nerve regeneration, functional recovery, reduced muscle atrophy, more myelination, and overall a good modulation in inflammatory cytokines and neurotrophic factors as compared to other experimental groups.ConclusionThe combinatorial application of VINCNPs and MenSCs in a PCL/collagen scaffold was able to support peripheral nerve regeneration and functional recovery. The bioengineered construct presented an alternative therapeutic strategy to autografts in the treatment of PNI that merits further study for clinical translation.Graphical Abstract Introduction Peripheral nerve injuries (PNIs) are among the most commonly occurring and challenging injuries to manage, especially in the context of concomitant complex bone fractures. These multifaceted injuries, resulting from a severe degree of trauma, such as high-velocity accidents, military combat, or catastrophic falls, give rise to a sequence of interrelated pathophysiological changes, including, but not limited to, disrupted nerve regeneration, muscle atrophy, and irreversible loss of sensory or motor function [1, 2]. The peripheral nervous system has a large potential to regenerate but the restoration of function is often incomplete and is even less when a nerve gap is present and the local environment is altered by inflammation and scarring [3]. Autologous nerve grafting remains the gold standard procedure for the bridging of large nerve gaps. However, due to the various limitations that exist such as donor site morbidity and limited supply, there is a substantial demand for alternative and effective treatment options that can facilitate peripheral nerve regeneration after trauma [4, 5]. Tissue engineering and regenerative medicine offer promising avenues for developing bioengineered neural guidance channels (NGCs) that can replicate the native nerve environment while supporting axonal growth and functional repair [6]. Recent progress in the areas of scaffold fabrication, bioactive molecule delivery and stem cell biology has allowed the development of highly complex biomimetic constructs. One such design of interest is that of electrospun nanofibrous scaffolds due to their high surface area, porosity, and mimicry of native extracellular matrix (ECM) architecture [7, 8]. Polycaprolactone (PCL), a synthetic, FDA-approved biodegradable polymer, is frequently used in electrospinning due to its mechanical strength and processability [9, 10]. However, its hydrophobicity and lack of bioactivity results in poor cell interaction and tissue integration. To address this, natural biopolymers such as collagen (a major component of the ECM) are often combined with PCL to promote cell attachment, proliferation, and differentiation [11]. We engineered a new nanocomposite neural guidance channel (NGC), which consisted of electrospun PCL/collagen scaffolds and collagen-based hydrogel laden with vinpocetine-entrapped chitosan nanoparticles along with menstrual blood-derived stem cells (MenSCs). The combined approaches can potentially overcome some of the existing challenges for nerve repair. The electrospun PCL/collagen scaffold formed the tubular wall of NGC, which offers structural support and guidance for the regenerating axons. The hydrogel placed inside the conduit, comprised of collagen, recapitulated the soft and hydrated environment of the native nerve tissue and acted as a depot for delivering the bioactive agents and cells [12]. One of the most innovative components of this system is the controlled delivery of vinpocetine, a synthetic derivative of the alkaloid vincamine, known for its neuroprotective, anti-inflammatory, and antioxidant properties [13, 14]. Vinpocetine inhibits phosphodiesterase type 1 (PDE1), thereby increasing intracellular cAMP and cGMP levels, which play a role in promoting neurite outgrowth and reducing inflammation [15, 16]. This drug shows promise as a neuroprotective and analgesic agent in models of peripheral nerve injury, mainly through mechanisms that reduce oxidative stress, enhance mitochondrial biogenesis, and suppress neuroinflammation and neuronal hyperexcitability [17]. It also promotes neuronal survival by regulating microglial cell activity and exosome release, limiting neuroinflammation and apoptosis [18]. However, poor aqueous solubility and short half-life have limited its therapeutic potential. Formulation of vinpocetine in chitosan nanoparticles offers the advantage of controlled release, better solubility, and stability [19]. Chitosan is a biocompatible and biodegradable polymer with inherent antimicrobial and wound healing properties, further enhancing the regenerative milieu [20]. Addition of MenSCs provides an active cellular component to the hydrogel construct. MenSCs are non-invasively derived mesenchymal stem cells from menstrual blood that exhibit regenerative potential because of their high proliferation rate, immunomodulation, and secretion of neurotrophic and angiogenic factors [21, 22]. In peripheral nerve repair, in addition to the potential of MenSCs to differentiate into Schwann-like cells, they could also promote axonal regrowth and myelination by paracrine mechanisms. MenSCs represent a more appealing cell source for clinical translation, relative to bone marrow- or adipose-derived MSCs, since they are abundant, ethically non-controversial, and are easily and less invasively obtained [23]. The overall concept is to provide a biomimetic scaffold that not only mimics the environment for nerve regeneration but can also actively promote the regenerative process by a combination of biomaterial, drug delivery and stem cell therapies. The present study is designed to assess the regenerative ability of the novel scaffold system in rat PNI model. Methods and materials Fabrication of electrospun PCL/collagen NGCs Electrospun PCL/collagen scaffolds were prepared by using acetic acid as a common solvent. PCL (MW ~80,000 Da, Sigma Aldrich, USA) and type I collagen extracted from rat tail were mixed in weight ratio of 80:20. In order to obtain the 12% w/v blended polymer solution, PCL was dissolved in glacial acetic acid (Merck, Germany) under constant magnetic stirring at room temperature to obtain a clear solution. Collagen was added slowly to PCL solution and the mixture was stirred continuously for 12 h. The polymer solution was filled in 10 mL syringe with a blunt-ended stainless steel needle (Gauge 18). The syringe was connected to a high-voltage power supply and placed on a syringe pump. Electrospinning was performed at an applied voltage of 20 kV, solution flow rate of 0.75 mL/h, and distance of 15 cm between the needle tip and the collector. The fibers were collected on a flat collector covered with aluminum foil under ambient conditions (22–25 °C, relative humidity 40–50%). After electrospinning for 10 h, a uniform nanofibrous mat with a thickness of 200 µm was formed. The scaffolds were peeled off from the collector and kept under vacuum at room temperature for 24 h to remove any remaining solvent. The scaffolds were then stored in a desiccator for further use. The electrospun sheets were rolled up 5 times to obtain neural tubes with almost 1000 µm thickness. Preparation of vinpocetine-loaded chitosan nanoparticles (VINCNPs) VINCNPs were synthesized by the ionic gelation method using sodium tripolyphosphate (TPP, Sigma Aldrich, USA) as the crosslinking agent. Chitosan (Sigma Aldrich, USA) was dissolved in 1% (v/v) acetic acid to prepare a 0.2% (w/v) chitosan solution and stirred by a magnetic stirrer at room temperature for 4 h to ensure that chitosan was completely dissolved and homogenous. Vinpocetine (Sigma Aldrich, USA) was added to the chitosan solution at 1% w/w and stirred for another 30 min for uniform distribution of the drug. Separately, 0.1% (w/v) of TPP was dissolved in deionized water to prepare the TPP solution. The TPP solution was added dropwise into the drug-loaded chitosan solution with magnetic stirring at 800 rpm. The ionic crosslinking between positively charged amino group of chitosan and negatively charged phosphate group of TPP resulted in the spontaneous formation of nanoparticles. The mixture was stirred continuously for 1 h to complete the crosslinking. The final nanoparticle suspension was centrifuged at 20,000 × g for 30 min at 4 °C. The supernatant was discarded and the pellet was washed twice with deionized water to remove the residual acetic acid and unencapsulated drug. The final VINCNPs were resuspended in deionized water and lyophilized for long-term storage. The nanoparticles were stored at −20 °C until use. Encapsulation efficacy and release assays The EE% of vinpocetine was estimated by using UV-Visible spectroscopy at 345 nm. A known volume of freshly prepared VINCNP suspension was centrifuged at 20,000 × g for 30 min at 4 °C to remove the unencapsulated drug. The supernatant was collected, and the concentration of the free vinpocetine was determined at 345 nm using a UV-Visible spectrophotometer using a blank of 1% acetic acid. The drug concentration was determined from a standard calibration curve of vinpocetine in the same solvent. The encapsulation efficiency was calculated using the following formula: For the in vitro release study, the lyophilized VINCNPs with a known quantity of vinpocetine were reconstituted in 5 mL of phosphate-buffered saline (PBS, pH 7.4) and loaded in the dialysis bags (molecular weight cut-off: 12–14 kDa). After closing the dialysis bags, 30 mL of PBS was added to individual conical tubes and dialysis bags were submerged in these tubes, then incubated at 37 ± 0.5 °C with continuous shaking at 100 rpm. Amount of 1 mL of release medium was drawn out at fixed time intervals, which was then replaced with an equal amount of fresh pre-warmed PBS (sink condition). All the collected samples were analyzed for the contents of vinpocetine by determining the absorbance at 345 nm on a UV-Visible spectrophotometer. The cumulative amount of drug released at different time intervals was calculated from the standard calibration curve and was represented as a percentage of the total amount of drug entrapped. All the studies were performed in triplicate. The results were presented as the cumulative percentage drug release versus time plot, to study the release profile of vinpocetine from nanoparticles for up to 7 days. Preparation of collagen hydrogel loaded with VINCNPs and MenSCs Collagen solution (5 mg/mL, Sigma Aldrich, USA) was combined with 2 w/w% VINCNPs on ice. MenSCs (human-derived, ATCC) passage 3 were suspended in DMEM-F12 culture media (ThermoFisher Scientific, USA) with 10% FBS and 1% antibiotics at 750,000 cells/mL and combined with equal volume of Collagen/VINCNPs solution on ice. The resulting solution was injected into the lumen of PCL/collagen NGCs after implantation. The hydrogel samples loaded with VINCNPs and MenSCs (named HYDVINMEN) and those without VINCNPs (named HYDMEN). Collagen only hydrogels (named COLHYD). Microstructure studies The microstructure of VINCNPs, electrospun PCL/collagen scaffolds, and freeze-dried hydrogel system was assessed using scanning electron microscopy (SEM). Briefly, the samples were cut and coated with gold for 250 s. Then, they were imaged under SEM at 25 kV accelerating high voltage. Cell viability assay on PCL/collagen scaffolds PC-12 cell viability cultured on electrospun PCL/collagen scaffolds was determined on day 1, 3, and 5 after cell seeding using MTT assay (Abcam, USA). Before cell seeding, the scaffolds were cut into circular-shaped discs, sterilized by incubating in 70% ethanol for 30 min, and exposed to ultraviolet (UV) for 30 min from each side. The scaffolds were rinsed three times in sterile phosphate-buffered saline (PBS), followed by pre-incubation in complete culture medium overnight at 37 °C for cell attachment enhancement. PC-12 cells (ATCC) were seeded at a density of 7000 cells per scaffold in 96-well plates. The cells were incubated at 37 °C in a humidified environment with 5% CO₂. On each time-point (day 1, 3, and 5), the culture medium was removed, and replaced with 200 µL of 0.5 mg/mL MTT solution. After 4 h of incubation at 37 °C, the MTT-containing medium was aspirated, and 200 µL of dimethyl sulfoxide (DMSO, Merck, Germany) was added to each well to dissolve the formazan product. The scaffolds were shaken for 10 min to dissolve the formazan product completely. Then, 100 µL of the obtained solution from each well was transferred into a 96-well plate, and the absorbance was read at 570 nm using a microplate reader. Cell viability assay on the hydrogel system HYDVINMEN and HYDMEN hydrogel cell viability at days 1, 3, and 5 post-embedding was determined by MTT assay. Collagen solution (5 mg/mL, Sigma-Aldrich, USA) was prepared on ice and mixed with 2% w/w vinpocetine-loaded chitosan nanoparticles (VINCNPs) to create the hydrogel base for the HYDVINMEN group. MenSCs (ATCC, human-derived, passage 3) were suspended in DMEM-F12 medium (ThermoFisher Scientific, USA) with 10% fetal bovine serum (FBS) and 1% antibiotic solution to a final concentration of 200,000 cells/mL for both the HYDVINMEN and HYDMEN groups. An equal volume of the cell suspension and collagen/VINCNPs mixture (HYDVINMEN) or collagen solution only (HYDMEN) was gently mixed on ice. 500 µL of the resulting cell-laden hydrogel (total of 50,000 cells) mixtures were cast into 24-well plates and incubated at 37 °C for 30 min for gelation. Once gelled, 500 µL of fresh complete DMEM-F12 medium was added to each well and incubated at 37 °C in a humidified 5% CO₂ atmosphere. Collagen-only hydrogels without VINCNPs (COLHYD) were used as a control. At days 1, 3, and 5, the medium was replaced with 500 µL of 0.5 mg/mL MTT solution. The hydrogels were incubated at 37 °C for 4 h to allow for metabolically active cells to reduce MTT to insoluble formazan crystals. After 4 h, the MTT-containing medium was removed, and 500 µL of dimethyl sulfoxide (DMSO) was added to each well and mixed to lyse the hydrogel and dissolve the formazan. The hydrogels were gently agitated for 10 min before 200 µL of the resulting solution from each well was transferred to a 96-well plate and absorbance was measured at 570 nm with a microplate reader. Mechanical strength analysis The mechanical properties of the electrospun PCL/collagen scaffolds were investigated by a uniaxial tensile test. The PCL/collagen scaffolds were cut to a rectangular shape with 30 mm length and 5 mm width. The thickness of each sample was measured by a digital micrometer at three different points. The average value of the three measurements was used for stress calculation. The mechanical properties were determined by a mechanical testing machine (Instron, USA) with a 10 N load cell. Two pneumatic grips were placed at both ends of the sample with a gauge length of 10 mm. The uniaxial tensile test was carried out at a constant crosshead speed of 1 mm/min until failure. Force-displacement data were collected to draw the stress-strain curves. The ultimate tensile strength (UTS) was calculated from the stress-strain curves. Swelling assay HYDVINMEN, HYDMEN, and COLHYD hydrogel samples were swollen in complete culture media for a period of 72 h. Prior to gelation, the original weight of each hydrogel sample was noted (W₀). The hydrogel samples were incubated with 5 mL of complete DMEM-F12 medium at 37 °C with 5% CO₂. At various time intervals, the hydrogels were carefully removed from the medium and were gently blotted with filter paper to remove the surface moisture and immediately weighed to note the swollen weight (W1). Each sample was then returned to fresh pre-warmed medium. The swelling ratio (%) was calculated using the following formula: Biodegradation assay Degradation of electrospun PCL/collagen scaffolds was studied by incubating the samples in complete culture medium for up to 60 days. Rectangular strips with equal size (10 mm × 10 mm) were cut from the scaffolds, and the initial dry weight (W0) was measured with an analytical balance. Samples were placed in individual wells of a 24-well plate, and 2 mL of complete DMEM-F12 culture medium containing 10% FBS and 1% antibiotic solution was added. The samples were incubated at 37 °C in a humidified incubator with 5% CO2. Culture media were changed to fresh pre-warmed medium every 3 days to keep media fresh and in physiological conditions. At the selected time points, the scaffold samples were retrieved from the culture medium and rinsed with PBS. After washing, they were dried in a vacuum desiccator at room temperature for 48 h until the weight was constant. Samples were weighed to obtain remaining dry weight (W1). The percentage of mass loss was calculated using the following formula: Hemocompatibility assay Hemocompatibility of HYDVINMEN, HYDMEN, COLHYD hydrogels and electrospun PCL/collagen scaffolds was assessed using fresh whole blood isolated from the healthy adult rats. All the animal experiments were carried out in accordance with institutional ethical guidelines and approved animal use protocols. The blood was collected via cardiac puncture from the anesthetized animals. Anticoagulant (ethylenediaminetetraacetic acid [EDTA]) was used for blood isolation. A 10 mm diameter sample disc from each group was incubated with 0.5 mL of diluted rat whole blood (1:1 dilution ratio using sterile PBS) in a 2 mL Eppendorf tube. The tubes were incubated at 37 °C for 1 h on a shaker at minimum speed to avoid hemolysis due to vibrations. Post incubation, the tubes were centrifuged at 1500 × g for 10 min, and supernatant was collected for further analysis. Hemoglobin release in the supernatant (resultant of hemolysis) was quantified using a UV-Visible spectrophotometer at 540 nm. Deionized water and PBS treated blood samples were used as 100 and 0% hemolysis (positive and negative) controls, respectively. In vivo study This study was approved by Ethics Committee of Taiyuan Central Hospital/The Ninth Clinical College of Shanxi Medical University (Approval Number: 2023041). The in vivo healing activity of the developed nerve guidance systems was evaluated in a rat model of sciatic nerve injury. A total of 30 adult male Wistar rats (250–300 g) were randomly divided into six groups (n = 5 per group) as follows: All animal procedures were conducted in accordance with institutional ethical guidelines and approved by the Institutional Animal Care and Use Committee. Group sizes (n = 5 a priori) were chosen based on the 3Rs principles of ethical reduction and the power estimate (G*Power, one-way ANOVA, α = 0.05, 1–β = 0.80, 6 groups) to find large effects (f ≈ 0.45–0.50) expected for autograft/HYDVINMEN versus blank/conduit-only based on our pilot data. Rats were anesthetized by intraperitoneal injection of ketamine (80 mg/kg) and xylazine (10 mg/kg). The left hind limb was shaved and disinfected and a skin incision was made to expose the sciatic nerve. In groups 1–5, a 10-mm segment of the sciatic nerve was excised to produce a critical-size defect. In groups 1–3, the defect was bridged with PCL/collagen conduits filled with the corresponding hydrogel formulation. In group 4, an empty conduit was implanted without filler. In group 5, the resected nerve segment was reversed and sutured back in as an autograft. Group 6 served as sham surgery and underwent only nerve exposure without transection. In all groups, the proximal and distal nerve stumps were inserted 1 mm into each end of the conduit (or sutured in the autograft group) and held in place by 8-0 nylon epineurial sutures under an operating microscope. The muscle and skin layers were then closed with absorbable sutures. The mice were monitored daily and treated with enrofloxacin (10 mg/kg, intraperitoneal) for 3 days after surgery. Animal welfare was monitored and implementation of all animal procedures was in accordance with the recommendations of the Institutional Animal Care and Use Committee. Body temperature was maintained with a heating pad. After surgery, postoperative analgesia was administered in the form of subcutaneous buprenorphine (0.05 mg/kg), which was given immediately after surgery and repeated every 12 h for 48 h. Postoperative care also included daily monitoring of signs of pain or distress (changes in grooming, posture, mobility and food/water consumption). Histological evaluation Animals were deeply anesthetized and sacrificed in accordance with the institutional ethical guidelines at 8 weeks post-surgery. The operated hind limb was dissected to identify and isolate the repair site of the sciatic nerve and the corresponding gastrocnemius muscle. The regenerated nerve segment including 5 mm of nerve distal and proximal to the repair site was carefully dissected using microsurgical instruments and removed from the wound without any undue mechanical manipulation or traction. Sciatic nerve samples were rinsed briefly in cold phosphate-buffered saline (PBS) and then fixed overnight in 10% Neutral Buffered Formalin (NBF) before paraffin embedding. Nerve samples were sectioned cross-sectionally in 5-µm-thick sections. H&E staining was used for overall tissue morphology, assessment of axonal bundles organization, inflammatory cells infiltration and fibrosis. Luxol fast blue (LFB) staining was used for selective visualization of myelinated fibers and to assess the extent and maturity of remyelination. The gastrocnemius muscles from the operated and contralateral limbs were exposed and resected. Samples were freed from excess connective tissue and rinsed briefly in PBS before being fixed in 10% NBF. After paraffin embedding, muscle samples were sectioned in transverse Section (5 µm) for histological evaluation. H&E staining was used to assess muscle fiber morphology, fiber diameter and cellular integrity, and to evaluate denervation-induced atrophy. Masson’s Trichrome staining was performed to evaluate collagen deposition and fibrosis (collagen fibers blue and muscle fibers red). Sensory and motor function recovery assays Sciatic Functional Index (SFI) Motor function recovery was evaluated by walking track analysis and sciatic functional index (SFI) calculation. Rats were trained to walk in a narrow corridor (8 cm wide and 50 cm long) covered with white paper. Before walking, hind paws were dipped in non-toxic ink to obtain a distinct footprint. At least three measurable footprints were recorded for each animal. SFI was calculated according to Bain formula, as described previously [24]. An SFI of 0 indicates normal function, while -100 corresponds to total dysfunction. Results were recorded for each animal and averaged per group. Hot plate latency test Animals were subjected to the hot plate test for assessment of recovery of sensory function at weeks 4 and 8 after surgery. The test apparatus was a digital hot plate analgesia meter, the temperature of which was kept constant at 52 ± 0.5 °C. Animals were allowed to acclimatize to the test environment for at least 30 min before the actual test. Rats were placed individually on the heated plate of the hot plate apparatus, and latency time (seconds) to a nociceptive response (licking, flicking, or rapid withdrawal of the operated hind paw) was measured. A cut-off time of 20 s was used to prevent tissue injury. If a rat did not respond to the heat stimulus within the 20-s time period, it was immediately removed from the apparatus, and the latency period was noted as 20 s. Each animal underwent three separate trials with 5 min between each trial. The mean of the latency time was calculated and used for statistical analysis. The longer latency times were considered indicative of decreased sensory function and the shorter latency times indicated restoration of nociceptive sensitivity. Gastrocnemius muscle atrophy assay The extent of muscle atrophy was determined by comparing the wet weight of the gastrocnemius muscle at week 8 after surgery. After euthanasia, the skin over the posterior area of both hind limbs was incised and the bilateral gastrocnemius muscles were exposed. The gastrocnemius muscles of each limb were dissected free from surrounding connective tissue and tendons without tension or injury. The excised muscles were wiped with sterile gauze to remove moisture and weighed on a high-precision digital scale. The wet weight of the operated gastrocnemius muscle was compared with the contralateral non-operated gastrocnemius muscle to assess the amount of muscle atrophy. The muscle atrophy index was calculated using the following formula: A value closer to 100% indicated minimal atrophy, while lower percentages reflected more severe muscle loss. All measurements were performed in triplicate, and results were expressed as mean ± standard deviation for each experimental group. ELISA assay At the end of 8th week, the animals were sacrificed and tissues were harvested and were flash-frozen. Then, the tissues were processed and their concentrations of TNF-α, IL-6, TGF-β, NGF, BDNF, b-FGF, and VEGF were assessed using ELISA assay kit (Abcam, USA) using the instructions provided by the manufacturer. Statistical analysis All quantitative data were expressed as mean ± standard deviation (SD). Statistical analyses were performed using GraphPad Prism version 5.0 (GraphPad Software, San Diego, CA, USA). One-way analysis of variance (ANOVA) followed by Tukey’s post hoc test was used for comparisons among multiple groups. A p-value of less than 0.05 was considered statistically significant. Results Microstructure assay results Representative SEM images to demonstrate the morphology of the fabricated electrospun scaffold, nanoparticles, and collagen-based hydrogels are shown in Fig. 1. The PCL/collagen electrospun scaffold was found to be made of randomly aligned, smooth nanofibers with a uniform diameter distribution, suggesting successful fabrication of the blend electrospun scaffold of the two polymers. VINCNPs were found to be spherical in shape with moderately smooth surfaces and a modest size distribution, while the blank chitosan nanoparticles (CNPs) were slightly more uniform in size with a similar spherical morphology. Scanning electron microscopy (SEM) images of the engineered components used in this study. A Electrospun PCL/collagen scaffold, B Vinpocetine-loaded chitosan nanoparticles (VINCNPs), C Blank chitosan nanoparticles (CNPs), D HYDVINMEN hydrogel (collagen hydrogel containing VINCNPs and MenSCs), E HYDMEN hydrogel (collagen hydrogel containing MenSCs), and F COLHYD hydrogel (collagen-only control) The cross-section of the three collagen-based hydrogels in the study showed visible and distinct internal structural differences. The HYDVINMEN hydrogel, which consisted of VINCNPs with MenSCs, presented a tight, interlinked porous morphology that is compact. The HYDMEN hydrogel, on the other hand, without the nanoparticles, appears looser with larger pores and a more fibrous structure. The COLHYD hydrogel that only contained collagen had a less defined structure, with a sheet-like morphology and barely noticeable pores. Cell viability assay results Results (Fig. 2) shows the MTT assay results with PC-12 cells and MenSCs cultured on PCL/collagen scaffolds and hydrogel systems. In panel A, both the PCL/collagen scaffold and the tissue culture plate control group supported progressive cell proliferation over time. Optical density values at 570 nm increased from day 1 to day 5 in both groups, indicating time-dependent cell growth. While there were no statistically significant differences between the groups at any time point, the PCL/collagen scaffold demonstrated a comparable or slightly higher metabolic activity than the control, suggesting good cytocompatibility of the electrospun structure. MTT assay results evaluating cell viability and metabolic activity. A PC-12 cell viability on PCL/collagen electrospun scaffolds compared to tissue culture plate control on days 1, 3, and 5. B MenSCs viability within HYDVINMEN, HYDMEN, and control (MenSCs on culture plate) over the same time points. Data are presented as mean ± SD (n = 3) Panel B shows the viability of MenSCs in HYDVINMEN, HYDMEN and control (MenSCs on tissue culture plate) groups. Optical density increased progressively over the 5 day period for all three groups, indicating continued proliferation of cells. The control group showed slightly higher absorbance values at the early time points, but by day 5, all 3 groups had similar optical density. These data indicate that hydrogel with or without VINCNPs supported MenSC viability and proliferation similar to standard culture conditions. Mechanical strength analysis Tensile strength analysis showed that PCL/collagen scaffolds had around 3.387 ± 0.434 MPa of ultimate tensile strength. Swelling and release assay results The swelling assay results (Fig. 3A) show the swelling kinetics of HYDVINMEN, HYDMEN, and COLHYD hydrogels in the complete culture media over 72 h. As can be seen in the figure, all the hydrogel samples had an initial rapid swelling during the early hours of incubation, and they reached the maximum swelling limit in the first 4–8 h. After that, the swelling was observed to gradually decrease in all the groups with time and was more obvious after 24 h. This may be due to some partial degradation or relaxation of the network. However, all three groups had a stable swelling profile throughout the entire study period, with no significant difference among them. This suggests that the incorporation of VINCNPs and/or MenSCs did not negatively impact the swelling behavior of the collagen-based hydrogel. Swelling assay results of hydrogels and cumulative release profile of vinpocetine from chitosan nanoparticles (VINCNPs). A Shows swelling behavior of HYDVINMEN, HYDMEN, and COLHYD hydrogels over 72 h of incubation in complete culture media at 37 °C. All groups showed a rapid increase in swelling within the first few hours, followed by a gradual decline over time. Data are presented as mean ± SD (n = 3). B Shows Cumulative release profile of VINCPs over 168 h in PBS at 37 °C. Data represent mean ± standard deviation (SD) from triplicate measurements (n = 3) Results showed that the EE% of vinpocetine into the VINCNPs was 44.78 ± 6.46%. The cumulative release profile of vinpocetine from VINCNPs exhibited a biphasic release pattern over a 7-day period (Fig. 3B). During the first 24 h, the cumulative release reached to 23.32 ± 6.12%. This rapid release phase likely corresponds to the diffusion of surface-bound drug. Following this, a sustained and gradual increase in release was observed, reaching 32.91 ± 4.39% at 48 h and 48.20 ± 5.10% at 72 h. The release continued to rise steadily, with values of 54.31 ± 8.28% at 120 h and 63.37 ± 5.05% at 168 h. Earlier time points showed lower but increasing release values, including 3.35 ± 2.61% at 2 h, 6.66 ± 1.99% at 6 h, and 13.66 ± 3.89% at 16 h. These results suggest that the VINCNPs provided an efficient and sustained release of vinpocetine, making them well-suited for applications requiring prolonged neuroprotective and anti-inflammatory effects in peripheral nerve injury treatment. Biodegradation assay Figure 4 illustrates the degradation profile of the PCL/collagen electrospun scaffold over a 60-day incubation period in complete culture media. The degradation rate (percentage of mass loss) continued to increase with time. There was a slow rate of degradation in the initial 20 days with a sudden increase from day 30. The maximum degradation was noted between days 30 and 60, which indicated a time-dependent degradation of the scaffold. At the end of 60th day, the degradation rate of the scaffolds was about 20.64 ± 1.83%. Degradation profile of electrospun PCL/collagen scaffolds during 60 days of incubation in complete DMEM-F12 culture media with 10% FBS and 1% antibiotics at 37 °C in a 5% CO₂ atmosphere. The % of mass loss was measured in time points, indicated that the scaffolds were degraded with a gradually increased rate of degradation. Data are mean ± SD (n = 3) Hemocompatibility assay results The hemocompatibility assay (Fig. 5) shows the percentage of hemolysis in different test samples upon incubation with rat whole blood. All the hydrogel as well as electrospun scaffold samples exhibited minimal hemolysis and are well below the 5% acceptable limit of hemolysis for blood contacting biomaterials. These data reveal that the evaluated formulations (HYDVINMEN, HYDMEN, COLHYD and PCL/collagen scaffold) are non-hemolytic and are expected to be applicable in vivo for blood contacting applications. Hemocompatibility evaluation of HYDVINMEN, HYDMEN, COLHYD, and PCL/collagen samples based on hemolysis assay using rat whole blood. Hemoglobin release was measured by optical density at 540 nm. The negative control (PBS-treated blood) and positive control (deionized water-treated blood) were included for comparison. * Indicates p-value < 0.05 relative to the positive control group Histological evaluation results Representative H&E staining images (Fig. 6) of sciatic nerve revealed that in the autograft group, the nerve fascicles are well-defined with a dense packing of axons and minimal disruption of connective tissue architecture. The fascicular pattern is clearly preserved, and there is strong, uniform LFB staining, which reflects extensive remyelination. This group is used as the gold standard for peripheral nerve repair, showing complete continuity of the nerve and robust regeneration of myelinated axons. In the HYDVINMEN group, the nerve fascicles appear as highly organized bundles of axons with reduced endoneurial spaces. There is minimal fibrotic infiltration, and the perineurium is well-demarcated. LFB staining demonstrates substantial reformation of the myelin sheaths with a consistent blue intensity across the majority of fascicles. In the HYDMEN group, the fascicles are moderately organized with increased inter-fascicular spaces and less dense axonal content compared to the autograft and HYDVINMEN groups. The LFB staining is evident but of lower intensity and uniformity, suggesting partial remyelination. In the COLHYD group, the overall nerve structure appears loosely organized with fragmented fascicles and increased fibrotic matrix deposition. H&E staining shows dispersed axonal profiles with mild infiltration of inflammatory cells, and LFB staining indicates weak and patchy myelination. In the PCL/Collagen Blank group, the nerve morphology is disrupted with poorly organized fascicles and scattered axonal fragments. The tissue is infiltrated by fibrous connective tissue, and LFB staining is minimal, reflecting insufficient remyelination. In the Negative control group, in which the nerve gap was left unrepaired, severe degeneration was observed. The fascicular structures appeared collapsed with extensive fibrosis and cellular disorganization. LFB staining was faint and irregular, confirming a lack of myelinated fiber regeneration. Photomicrographs of representative sciatic nerve cross-sections that were regenerated in different groups at 8 weeks after surgery. Hematoxylin and Eosin (H&E) staining (left column) and Luxol Fast Blue (LFB) staining (right column). Magnification of all photomicrographs was kept identical. Scale bar: 100 µm H&E and Masson’s Trichrome staining images of the gastrocnemius muscle are shown in Fig. 7. On H&E staining of the autograft group, muscle fibers were well organized, with a consistent polygonal morphology and minimal interstitial space, showing no significant evidence of atrophy. This was further supported by Masson’s Trichrome staining, which demonstrated limited collagen deposition, consistent with the expected gold-standard performance of autografts, including negligible fibrosis and complete muscle reinnervation. On H&E staining of the HYDVINMEN group, the fibers were generally well-preserved and showed mild variations in size. The architecture was relatively preserved in this group, as visualized on H&E staining, and Masson’s Trichrome staining revealed low collagen deposition, indicating minimal fibrotic remodeling. On H&E staining of the HYDMEN group, muscle showed signs of moderate degeneration. The stained sections demonstrated a higher degree of fiber size variability and early angular atrophy with more apparent inter-fiber spaces. On Masson’s Trichrome staining of the HYDMEN group, moderate collagen accumulation was noted, which is consistent with the expected incomplete reinnervation and progressive fibrotic changes. On H&E staining of the COLHYD group, the muscle fibers were more irregular and smaller with indications of moderate atrophy. The H&E-stained sections were partially preserved, while Masson’s Trichrome staining revealed more extensive collagen infiltration compared to cell-loaded hydrogels, suggesting that the collagen matrix alone was insufficient to support muscle structure and prevent degradation and fibrosis. On H&E staining of the PCL/Collagen Blank group, the muscle fibers showed signs of atrophy with irregular, angular shapes and increased endomysial space. Masson’s Trichrome staining of the PCL/Collagen Blank group highlighted substantial collagen deposition, indicating significant fibrosis due to poor functional recovery in the absence of supportive cellular or therapeutic agents. On H&E staining of the negative control group, which did not receive any treatment, severe degeneration of the muscle was observed, characterized by fragmented and disorganized fibers. This was confirmed on Masson’s Trichrome staining, with an intense blue hue permeating the section, indicative of extensive fibrotic tissue replacement. Photomicrographs of representative gastrocnemius muscle cross-sections of different groups 8 weeks after sciatic nerve injury. Left column: Hematoxylin and Eosin (H&E) staining. Right column: Masson’s Trichrome staining (collagen deposition appears blue). All photomicrographs are at the same magnification with a scale bar of 100 µm SFI assay results At week 4 and 8 (Fig. 8), the autograft and HYDVINMEN groups had the best functional recovery compared to all other groups, as they had the highest (least negative) SFI values. The HYDMEN, COLHYD, and PCL/Collagen Blank groups had significantly worse functional outcomes with lower SFI values. The negative control group had the worst function as they had the lowest SFI values at both time points. The autograft group had significantly higher SFI values compared to the HYDVINMEN group. Sciatic Functional Index (SFI) scores measured at weeks 4 and 8 post-sciatic nerve injury for different treatment groups. Higher (less negative) SFI values indicate better motor functional recovery. Data are presented as mean ± SD (n = 5 per group). *p < 0.05 compared to the HYDVINMEN group; #p < 0.05 compared to the autograft group Hotplate latency assay results The autograft group had the lowest latency time, meaning that they had the most complete sensory recovery of all the groups (Fig. 9). HYDMEN, COLHYD, and PCL/Collagen Blank groups all had significantly higher latency times than the HYDVINMEN group (*p < 0.05). Autograft group had significantly lower latency time than the HYDVINMEN group. The negative control group had the highest latency as there was no nerve recovery without treatment. Hot plate latency results in a test of sensory functional recovery in the various experimental groups, 8 weeks after sciatic nerve injury. The latency time in seconds, represents the time taken for paw withdrawal after a thermal stimulus, with faster responses indicative of better recovery. Data are presented as mean ± SD (n = 5 per group). *p < 0.05 compared to the HYDVINMEN group; #p < 0.05 compared to the autograft group Gastrocnemius muscle weight loss The autograft group had the lowest degree of atrophy, which validated the ability of the autograft to prevent muscle atrophy via complete nerve regeneration. The HYDVINMEN group had an intermediate level of weight loss, significantly less than all other treatment groups (except autograft), indicating successful muscle reinnervation via the combined delivery of VINCNPs and MenSCs. The HYDMEN, COLHYD and PCL/Collagen Blank groups had significantly higher degrees of muscle weight loss than both HYDVINMEN (*) and autograft (#), while the negative control had nearly complete loss of muscle mass, indicating that the muscle was not reinnervated in the absence of any treatment (Fig. 10). Percentage of gastrocnemius muscle wet weight loss in different experimental groups at 8 weeks post-sciatic nerve injury. Higher values indicate greater muscle atrophy due to insufficient reinnervation. Data are presented as mean ± SD (n = 5 per group). *p < 0.05 compared to the HYDVINMEN group; #p < 0.05 compared to the autograft group ELISA assay results As shown in the results (Fig. 11), the TGF-β content was significantly higher in the HYDVINMEN group and autograft group than that in all other groups, showing a significant improvement in anti-inflammatory and regeneration factors. b-FGF, VEGF, NGF, and BDNF contents also had a similar trend; the HYDVINMEN group and autograft group were significantly higher than all other groups in all markers, indicating a strong neurotrophic and angiogenic effect. In contrast, the TNF-α and IL-6 contents were significantly higher in the negative control group and PCL/Collagen Blank group than in all other groups and were significantly lower in the HYDVINMEN group, confirming the strong anti-inflammatory effect. ELISA analysis of cytokine and growth factor expression levels in regenerated sciatic nerve tissue across different experimental groups at 8 weeks post-injury. Quantified proteins include TGF-β, b-FGF, IL-6, NGF, VEGF, TNF-α, and BDNF. Data are expressed as mean ± SD (n = 3). Symbols indicate statistically significant differences (p < 0.05) as follows: @ vs. HYDVINMEN, # vs. HYDMEN, $ vs. COLHYD, % vs. PCL/Collagen Blank, and ^ vs. Autograft Discussion Drug and cell delivery NGCs are biomaterials engineered for PNI repair. These conduits resemble native nerve tissue and provide physical guidance for axonal regeneration. Incorporating therapeutic molecules and regenerative cells into NGCs can enhance axonal growth, modulate inflammation and promote remyelination [25, 26]. Controlled drug release and cell integration within the scaffold promote the recovery of function. In this study, we developed an advanced delivery system for vinpocetine and MenSCs administration to the nerve tissue. The drug delivery system we developed was able to release the loaded drug in a sustained manner. This result could be attributed to the diffusion, swelling, and gradual biodegradation of chitosan’s polymeric backbone [20, 27]. The successful encapsulation of vinpocetine into CNPs can be attributed to the ionic interaction between chitosan and TPP, which induces the condensation of the chitosan–drug mixture [28]. This ionotropic gelation process can provide a stable nanoparticulate matrix that successfully entrap vinpocetine into the chitosan matrix. Electrostatic interaction between the positively charged amino groups of chitosan and the negatively charged phosphate groups of TPP may increase the entrapment efficiency while preserving the physicochemical stability and homogeneity of the nanoparticles [29, 30]. The fiber diameter distribution from the SEM images reveals a relatively uniform size distribution, which confirms the stability and efficiency of the electrospinning process in producing nanofibrous structures. The microstructure of electrospun NGCs have been reported to be conductive for the promotion of neural cells adhesion, proliferation, and migration [31, 32]. SEM images of nanocarriers showed that the particles were spherical with a relatively smooth surface. The associated histogram shows a narrow size distribution of the particles indicating a good control of the synthesis as well as their homogeneity. The HYDVINMEN hydrogel had a dense and very interconnected porous network containing fibrous strands that can enhance the diffusion of nutrients, and [33]. The presence of VINCNPs likely contributed to the enhanced structural integrity and matrix organization [34, 35]. The biocompatibility of the electrospun PCL/collagen scaffolds and the collagen-based hydrogel systems was validated by MTT assay. A time-dependent increase in the optical density revealed that the physicochemical characteristics of the biomaterials maintained the cell viability and proliferation over time and could be used as bioengineered neural substrates. The cells showed sustained metabolic activity indicating good cell–material interactions. The nanofibrous PCL/collagen scaffold, with the topography similar to that of native ECM, was responsible for the neural cell adhesion and metabolism [36]. As expected, the collagen-based hydrogels with or without VINCNPs also provided a soft hydrated environment for survival and proliferation of MenSC. The similar cellular metabolic activity observed between biomaterial groups and the standard culture conditions indicated that the biomaterials exhibited low cytotoxicity and sufficient nutrient diffusion. The measured ultimate tensile strength of the PCL/collagen electrospun scaffold was ~3.39 ± 0.43 MPa. This value is within the range of the reported native tensile strength of peripheral nerves which have been reported to be in the range of 1–3 MPa depending on the nerve type, species, and test conditions. For instance, the rat sciatic nerve was reported to be ~1.5–2.0 MPa, while human peripheral nerves were 2–3 MPa [37–39]. Results from swelling assays of HYDVINMEN, HYDMEN and COLHYD hydrogels suggest that in an artificial physiological environment, the HYDVINMEN, HYDMEN and COLHYD hydrogels have a high hydration capacity and maintain their structural integrity. Swelling of all hydrogel compositions followed a fast initial water uptake and reached a maximum swelling after few hours, which is typical for collagen based hydrogels with a highly porous network [40, 41]. The further gradual reduction in swelling, especially after 24 h, indicates controlled degradation or polymer relaxation over time. The lack of significant differences between the groups suggests that the addition of VINCNPs and/or MenSCs did not compromise the hydrogel’s fluid absorption and retention capabilities. The degradation behavior observed for the PCL/collagen electrospun scaffold is primarily attributed to the hydrolytic breakdown of its polymeric components. PCL degrades slowly through hydrolysis of its ester bonds, providing mechanical stability over an extended period [42]. In contrast, collagen, being a natural protein, undergoes more rapid enzymatic and hydrolytic degradation, particularly in the presence of physiological fluids and matrix metalloproteinases (MMPs) [43]. The biphasic mass loss profile – initial mass stability followed by rapid degradation – may be a result of the initial stability of PCL and a time dependent progressive degradation of collagen, leading to an increase in surface area and porosity which enables fluid transport and hydrolysis. The time dependent controlled degradation profile that has been observed is of great importance for peripheral nerve repair. Controlled, time dependent degradation of a nerve conduit scaffold is required for maintaining the conduit during the initial stages of axonal regrowth and cell infiltration which needs mechanical guidance, and then minimizing the presence of a chronic foreign body to allow for remodeling of native tissue, minimizing long term inflammation or fibrotic encapsulation [6, 44, 45]. The hemocompatibility assay results revealed that the tested biomaterials, including HYDVINMEN, HYDMEN, COLHYD, and PCL/collagen scaffolds, produced significantly less hemolysis than the positive control. Furthermore, all groups showed values less than the critical 5% threshold. These results demonstrated the blood compatibility of the biomaterials. The in vivo study showed that the HYDVINMEN group had superior sensory, motor, and tissue recovery compared with other groups except for the autograft group. The improved healing in the HYDVINMEN group was accompanied by increased tissue levels of pro-regenerative proteins and decreased pro-inflammatory cytokine concentrations. The results observed could have been due to the co-delivery of MenSCs and vinpocetine through the neural channel. Indeed, the neuroprotective function of vinpocetine has been well-documented in previous studies. Yelkenchi et al. showed that vinpocetine, which is a neuroprotective agent with anti-inflammatory and antioxidant effects, mitigated brain injury in a cold-induced mouse model of traumatic brain injury (TBI). Treatment resulted in a marked reduction of infarct volume, brain edema, blood–brain barrier damage and DNA fragmentation. Recovery of neuronal survival, motor function and neurogenesis was also demonstrated. Proteomic analysis revealed 192 proteins to be modulated by vinpocetine, which may represent putative therapeutic targets. These data support the notion that vinpocetine exerts its therapeutic effects after TBI by the promotion of tissue protection and repair mechanisms [46]. Vinpocetine improved dyskinesia in Parkinson’s disease rats by reducing oxidative stress, increasing antioxidant activity, and activating the Wnt/β-catenin signaling pathway, leading to better motor function and neuronal protection [47]. This drug also significantly reduced methotrexate-induced hippocampal toxicity in rats by activating Keap-1/Nrf2 antioxidant signaling, suppressing NF-κB/AP-1 inflammation, and modulating apoptotic markers, thereby protecting neurons and improving hippocampal integrity [48]. Furthermore, the neuroprotective effect of MenSCs administration has been demonstrated in the previous report. Wu et al. reported that MenSCs significantly improved functional recovery in rat spinal cord hemisection model through increasing BDNF expression, promoting axonal regeneration, decreasing the inflammatory cytokines (TNF-α, IL-1β), and restricting cavity formation [23]. Brolongan et al. provided evidence that MenSCs displayed stem cell–like and neuronal markers and could exert neuroprotection in stroke models by paracrine release of neurotrophic factors including BDNF, VEGF, and NT-3. The neurotrophic factors ameliorate stroke by reducing neuronal death, increasing cell survival, and improving behavioral outcomes [49]. Considering our own observations and those of others, we hypothesize that MenSCs and vinpocetine had a synergistic effect on the repair of PNI. We suspect that this therapeutic intervention may have targeted multiple pathways not studied here and should be investigated. Conclusion This work introduces a new multifunctional neural guidance channel, based on electrospun PCL/collagen scaffolds integrated with a collagen-based hydrogel containing VINCNPs and MenSCs for PNI treatment. The construct has shown to have very good physicochemical properties, including proper mechanical behavior, swelling, degradation, and hemocompatibility. The scaffolds and hydrogels are also biocompatible in vitro assays, as they allow cell viability and proliferation. HYDVINMEN implanted in the host exhibits a great enhancement in sensory and motor functional recovery, and the prevention of muscle atrophy, axonal regeneration, and remyelination, as well as a modulation of inflammatory and neurotrophic signaling markers. All these observed effects can be expected to be the result of a combination of vinpocetine and MenSCs action. However, the molecular mechanisms underlying these responses need to be better characterized. As a potential alternative for autografting, the platform will require further efforts to address more translational issues, such as confirmation of the results in larger animals, more relevant to the clinic, the development of standardized manufacturing and sterilization processes for the conduit and hydrogel, and definition of cell- and drug-related release parameters in preclinical regulatory terms. These processes will be required to further approach the integrated biomaterial–cell–drug system toward the clinic and future clinical translation. Data availability Data will be made available upon request. Compliance with ethical standards Conflict of interest The authors declare no competing interests. Ethics approval This study was approved by Ethics Committee of Taiyuan Central Hospital/The Ninth Clinical College of Shanxi Medical University (Approval Number: 2023041). Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement Data will be made available upon request.